RGCC SA a world-class laboratory which specialises in medical genetics and in particular cancer genetics, providing a global service. By using the most advanced and innovative technologies of molecular and cellular biology, R.G.C.C. International SA manages to overcome some of restrictions that are involved in the analysis of CTCs (Circulating Tumor Cells) and CSCs (Circulating Stem Cells). R.G.C.C. International SAs offering methods in clinical practice such as new and precise assays, risk scale and classification of cancer patients.
Personalized Cancer Care featuring Circulating Tumor Cell analysis
CTCs are cancer cells originated from solid tumor dispersed in the peripheral blood. It is generally explained that these cells are detached from the primary or secondary tumors of patients with advanced cancer prior to detection in the blood circulation. CTCs number is considered very less, with an estimated number of one in 100 million to one in a billion blood cells.